Vestal Point Capital, LP Xenon Pharmaceuticals Inc. Transaction History
Vestal Point Capital, LP
- $1.21 Trillion
- Q1 2024
A detailed history of Vestal Point Capital, LP transactions in Xenon Pharmaceuticals Inc. stock. As of the latest transaction made, Vestal Point Capital, LP holds 400,000 shares of XENE stock, worth $15.6 Million. This represents 1.42% of its overall portfolio holdings.
Number of Shares
400,000
Previous 175,000
128.57%
Holding current value
$15.6 Million
Previous $8.06 Billion
113.63%
% of portfolio
1.42%
Previous 0.85%
Shares
2 transactions
Others Institutions Holding XENE
# of Institutions
227Shares Held
69MCall Options Held
307KPut Options Held
68.9K-
Avoro Capital Advisors LLC New York, NY5.67MShares$221 Million2.94% of portfolio
-
Driehaus Capital Management LLC Chicago, IL4.32MShares$169 Million2.04% of portfolio
-
Wellington Management Group LLP Boston, MA3.92MShares$153 Million0.03% of portfolio
-
Capital World Investors Los Angeles, CA2.68MShares$105 Million0.02% of portfolio
-
Polar Capital Holdings PLC London, X02.61MShares$102 Million0.7% of portfolio
About Xenon Pharmaceuticals Inc.
- Ticker XENE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 62,263,500
- Market Cap $2.43B
- Description
- Xenon Pharmaceuticals Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutics to treat patients with neurological disorders in Canada. Its clinical development pipeline includes XEN496, A Kv7 potassium channel opener that is Phase III clinical trials for the treatment of KCNQ2 developmental and epilepsy encephalopath...